Literature DB >> 32269087

Novel coronavirus infection in newborn babies aged <28 days in China.

Zhi-Jiang Zhang1,2, Xue-Jie Yu3,2, Tao Fu4,2, Yu Liu5, Yan Jiang4, Bing Xiang Yang6, Yongyi Bi3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32269087      PMCID: PMC7144267          DOI: 10.1183/13993003.00697-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: The outbreak of coronavirus disease 2019 (COVID-19) is spreading rapidly [1-8]. On 31 January 2020, the World Health Organization declared COVID-19 a public health emergency of international concern. By 13 March 2020, COVID-19 had been confirmed in 127 countries, with 145 166 cases and 5428 deaths worldwide. At an early stage of the epidemic, older adults were reported to be more likely to be infected [1-8]. Subsequently, infections in infants under 1 year of age were reported [8]. To date, little is known about the infection in newborn babies. Furthermore, data regarding intrauterine transmission are scarce [9]. In this study, we identified all infected newborn babies in China by 13 March 2020 and describe the clinical features, treatment, outcomes and intrauterine transmission potential. For this retrospective study, we identified all neonatal infections with the COVID-19 virus, SARS-CoV-2, between 8 December 2019 and 13 March 2020 in China. The summary number of new infections was released daily by the National Health Commission in China [10]. We systematically explored all the 81 026 cases that were laboratory-confirmed by 13 March 2020, as described previously [8]. In short, we retrieved the summary data from the central government and local health departments and screened for newborn babies <28 days of age. Local hospitals, administrative offices and families of patients were interviewed through telephone or online communication tools. This study was approved by the institutional review board of Wuhan University School of Health Sciences. The need for informed consent was waived as part of the public health outbreak investigation. Data on the demographics, disease onset, diagnosis, treatment and outcomes were collected using standard forms. To analyse the intrauterine transmission potential, data were collected on the mother's disease onset (symptoms, timing of symptoms onset relative to delivery), diagnosis, Wuhan linkage (living in or visited Wuhan, or directly contacting visitors from Wuhan), delivery (delivery methods, hospital level, protection level, gestational age at delivery) and mother–child contact (separation, breastfeeding). To detect neonatal infection, nasopharyngeal swabs or anal swabs were collected during hospitalisation. Quantitative real-time PCR was used according to the recommended protocol [11]. IgM/IgG antibodies were not used in the present study because this technology has been developed recently and had not been widely used at this stage. For the mothers of the newborn babies, computed tomography (CT) scanning was used for preliminary screening. Abnormal results included ground-glass opacity and bilateral patchy shadowing. Suspected infection was defined as abnormal results on CT scanning coupled with typical clinical symptoms, including fever, cough, headache, sore throat, shortness of breath and sputum production. Nasopharyngeal swabs were collected for detection of SARS-CoV-2 nucleic acid. Confirmation of infection in mothers was based on nucleic acid tests. Based on the data sources we used in this retrospective study, four nucleic acid-confirmed neonatal infections were identified through systematic and comprehensive searching among the 81 026 confirmed cases in China as of 13 March 2020 (table 1). All four patients were hospitalised. Three were male. The age at diagnosis ranged from 30 h to 17 days.
TABLE 1

Characteristics of four hospitalised nucleic acid-confirmed infections in newborn babies

Patient 1Patient 2Patient 3Patient 4
Demographics
 SexMaleMaleMaleFemale
 Age at diagnosis30 h17 days5 days5 days
Disease onset
 Onset of symptomsShortness of breathFever, cough, vomitingFeverNo symptoms
 Setting of disease onsetHospitalHomeHomeHospital
 Status of isolationIsolated in hospitalNo isolationNo isolationIsolated in hospital
Diagnosis
 Nucleic acid detectionYesYesYesYes
 Time between symptoms onset and nucleic acid diagnosisSame day2 daysSame day5 days#
 Nucleic acid specimen swabNasopharyngealAnalAnalNasopharyngeal
 CT scan testIncreased lung markingIncreased lung markingIncreased lung marking
Treatment
 Supportive treatmentYesYesYesYes
 Intensive care unitNoNoNoNo
 Mechanical ventilationNoNoNoNo
Outcomes
 Any severe complicationsNoNoNoNo
 Hospital stay days14233016
Mother's disease onset
 SymptomsFeverCoughFever, cough, appetite decline, oil intoleranceFever
 Timing of symptoms onsetBefore deliveryAfter deliveryBefore deliveryBefore delivery
Mother's disease diagnosis
 Infection statusYesYesYesYes
 CT diagnosisBefore deliveryAfter deliveryBefore deliveryBefore delivery
 Nucleic acid detectionAfter deliveryAfter deliveryAfter deliveryAfter delivery
Epidemiology
 Linkage to WuhanResiding in WuhanResiding in WuhanVisiting WuhanResiding in Wuhan
 Contact with patientsNoHousehold memberNoNo
Delivery
 Method of deliveryCaesareanCaesareanCaesareanCaesarean
 Hospital levelIIIIIIIIIII
 Protection levelIIIIIIIIIII
 Gestational age39 weeks, 6 daysMatureMature40 weeks, 1 day
Mother–child contact
 Immediate separationYesNoYesYes
 BreastfeedingNoYesNoNo

CT: computed tomography. #: time between date of birth and diagnosis.

Characteristics of four hospitalised nucleic acid-confirmed infections in newborn babies CT: computed tomography. #: time between date of birth and diagnosis. Two newborn babies had fever, one had shortness of breath, one had cough and one had no noticeable symptoms. The onset of disease occurred in hospital for two newborn babies and at home for two newborn babies. Two newborn babies were in isolation and two were not in isolation at the time of disease onset. Nucleic acid detection was performed using nasopharyngeal swabs for two newborn babies and anal swabs for two newborn babies. All four newborn babies tested positive for SARS-CoV-2 nucleic acid. CT scans were performed in three newborn babies. All showed increased lung marking. The time between dates of admission/symptoms and diagnosis was 0–2 days. Supportive treatment was provided for all four newborn babies. None required intensive unit care or mechanical ventilation. None had any severe complications. Three newborn babies were deemed to recover after two consecutive negative nucleic acid tests (separated by ≥24 h). Their hospital stay was 16, 23 and 30 days, respectively. All four newborn babies’ mothers were diagnosed as infected. Three mothers showed symptoms before delivery and one after delivery. The most common symptoms in mothers were fever, followed by cough, appetite decline and oil intolerance. CT scans were performed for all four mothers, with three before and one after delivery. Abnormal findings were reported for all mothers. Nucleic acid detection was performed for all four mothers, with three after delivery and one before delivery. All four mothers tested positive for SARS-CoV-2 nucleic acid. Caesarean section was used for all four mothers, three at level III hospitals and one at a level II hospital. The protection level was III for three mothers and II for one mother. Three newborn babies were separated from their mothers immediately after being born and were not breastfed; one neonate had not been separated from the mother and was breastfed for 16 days until symptom onset. Based on these findings, symptoms of neonatal infection appear to be generally mild compared to adult patients. No severe clinical complications or deaths were observed in newborn babies, compared to fatality rates of ∼4–15% in adults [1-4]. Note that infants <1 year of age also presented mild or no symptoms and rarely severe complications [8]. On the one hand, it is encouraging that newborn babies and infants appear to have mild symptoms, although close monitoring for clinical deterioration is still necessary. On the other hand, mild or no symptoms in the youngest make it difficult to detect and prevent further transmission of this virus in the general population. The number of neonatal infections was four, compared to the previously reported nine infections in infants aged between 28 days and 1 year [8]. Proportionately, the infection rate might be higher in newborn babies than infants. Different exposure chances may partly explain the different infection rates, but different transmission routes may be another explanation. Vertical transmission may be an additional route for infections in newborn babies but not possible for infants, although a previous study of six pregnant women did not find any direct evidence [9]. The findings of the present study suggest intrauterine transmission potential. All four newborn babies were delivered through caesarean section and three were under level III protection. The possibility of intrapartum mother-to-child transmission by vaginal delivery was excluded. Except for patient 2 having contact with an infected visitor, all the other three newborn babies were in isolation when symptoms occurred. No mother–child contact or breastfeeding occurred in these three newborn babies. The time between birth and diagnosis was limited, ranging between 30 h and 5 days. Taken together, the chance of infection through ways other than intrauterine transmission is deemed to be low. However, there are other explanations for neonatal infections. Firstly, the possibility of nosocomial infection cannot be completely ruled out. Secondly, nasopharyngeal and anal swabs cannot directly indicate intrauterine infection, and no viral particles were found in the amniotic fluid or cord blood from six patients [9]. Thirdly, the number of neonatal infections is small, although it is possible that the identification of cases was incomplete due to a lack of identifying information for newborn babies. Fourthly, SARS-CoV, another coronavirus with a similar genome sequence [12], was not found to be vertically transmitted [13, 14]. Further research is warranted. There are limitations to the present study. First, although a systematic and comprehensive search was made for SARS-CoV-2 infection in newborn babies <28 days of age, incomplete identification of cases is possible. Secondly, the present study identified mostly symptomatic patients. However, asymptomatic infection exists for COVID-19 [8, 15]. Thirdly, intrauterine tissue samples were not collected for these four newborn babies. Direct intrauterine detection of SARS-CoV-2 was not possible in the present study. In summary, newborn babies are susceptible to SARS-CoV-2 infection. The symptoms in newborn babies were milder and outcomes were less severe compared to adult patients. Intrauterine vertical transmission is not impossible, and further studies are warranted to search for virological evidence. This one-page PDF can be shared freely online. Shareable PDF ERJ-00697-2020.Shareable
  13 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Infants born to mothers with severe acute respiratory syndrome.

Authors:  Chi C Shek; Pak C Ng; Genevieve P G Fung; Frankie W T Cheng; Paul K S Chan; Malik J S Peiris; Kim H Lee; Shell F Wong; Hon M Cheung; Albert M Li; Ellis K L Hon; Chung K Yeung; Chun B Chow; John S Tam; Man C Chiu; Tai F Fok
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Authors:  Huijun Chen; Juanjuan Guo; Chen Wang; Fan Luo; Xuechen Yu; Wei Zhang; Jiafu Li; Dongchi Zhao; Dan Xu; Qing Gong; Jing Liao; Huixia Yang; Wei Hou; Yuanzhen Zhang
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

9.  Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.

Authors:  Wen-Hua Liang; Wei-Jie Guan; Cai-Chen Li; Yi-Min Li; Heng-Rui Liang; Yi Zhao; Xiao-Qing Liu; Ling Sang; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Wei Wang; Qi-Hua He; Zi-Sheng Chen; Sook-San Wong; Mark Zanin; Jun Liu; Xin Xu; Jun Huang; Jian-Fu Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zhan-Hong Xie; Zheng-Yi Ni; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-06-04       Impact factor: 16.671

10.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome.

Authors:  Shell F Wong; Kam M Chow; Tse N Leung; Wai F Ng; Tak K Ng; Chi C Shek; Pak C Ng; Pansy W Y Lam; Lau C Ho; William W K To; Sik T Lai; Wing W Yan; Peggy Y H Tan
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

View more
  42 in total

1.  Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19.

Authors:  Roghayeh Babaei; Farah Bokharaei-Salim; Khadijeh Khanaliha; Seyed Jalal Kiani; Arezoo Marjani; Saba Garshasbi; Farzaneh Dehghani-Dehej; Sara Chavoshpour
Journal:  BMC Infect Dis       Date:  2022-09-08       Impact factor: 3.667

2.  Chest computed tomography findings of COVID-19 in children younger than 1 year: a systematic review.

Authors:  Alireza Ghodsi; Moniba Bijari; Seyed Ali Alamdaran; Amin Saberi; Elnaz Mahmoudabadi; Mohammad Reza Balali; Sara Ghahremani
Journal:  World J Pediatr       Date:  2021-05-07       Impact factor: 2.764

Review 3.  SARS-CoV-2 Infection and the Newborn.

Authors:  Fahri Ovalı
Journal:  Front Pediatr       Date:  2020-05-22       Impact factor: 3.418

Review 4.  The clinical course of SARS-CoV-2 positive neonates.

Authors:  Giuseppe De Bernardo; Maurizio Giordano; Giada Zollo; Fabrizia Chiatto; Desiree Sordino; Rita De Santis; Serafina Perrone
Journal:  J Perinatol       Date:  2020-07-06       Impact factor: 2.521

Review 5.  COVID-19 and newborn health: systematic review.

Authors:  Pablo Duran; Stephen Berman; Susan Niermeyer; Thomas Jaenisch; Thais Forster; Rodolfo Gomez Ponce de Leon; Bremen De Mucio; Suzanne Serruya
Journal:  Rev Panam Salud Publica       Date:  2020-04-27

Review 6.  COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies.

Authors:  Giulia Trippella; Martina Ciarcià; Marta Ferrari; Chiara Buzzatti; Ilaria Maccora; Chiara Azzari; Carlo Dani; Luisa Galli; Elena Chiappini
Journal:  Pathogens       Date:  2020-06-18

7.  AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.

Authors:  Bijon Kumar Sil; Mohd Raeed Jamiruddin; Md Ahsanul Haq; Mohib Ullah Khondoker; Nowshin Jahan; Shahad Saif Khandker; Tamanna Ali; Mumtarin Jannat Oishee; Taku Kaitsuka; Masayasu Mie; Kazuhito Tomizawa; Eiry Kobatake; Mainul Haque; Nihad Adnan
Journal:  Int J Nanomedicine       Date:  2021-07-09

8.  The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: A meta-analysis and systematic review.

Authors:  Xuefeng Ma; Shousheng Liu; Lizhen Chen; Likun Zhuang; Jie Zhang; Yongning Xin
Journal:  J Med Virol       Date:  2020-07-06       Impact factor: 20.693

Review 9.  Age-Related Morbidity and Mortality among Patients with COVID-19.

Authors:  Seung Ji Kang; Sook In Jung
Journal:  Infect Chemother       Date:  2020-06-12

10.  Postnatal SARS-CoV-2 infection and immunological reaction: A prospective family cohort study.

Authors:  Julia Preßler; Sara Fill Malfertheiner; Michael Kabesch; Heike Buntrock-Döpke; Sebastian Häusler; Andreas Ambrosch; Sven Wellmann
Journal:  Pediatr Allergy Immunol       Date:  2020-06-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.